{
  "main_header": {
    "sid": 779371,
    "name": "Titan Biotech",
    "stock_name": "Titan Biotech",
    "full_name": "Titan Biotech Ltd",
    "name_url": "stocks-analysis/titan-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "430.00",
    "chg": -2.4,
    "chgp": "-0.56%",
    "dir": -1,
    "prev_price": "432.40",
    "mcapval": "1,797.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524717,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE150C01029",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "11.61 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/titan-biotech-779371-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 364,
    "sid": "779371",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/titan-biotech-779371"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Jun-2026",
      "details": "Newspaper publication of the Audited Financial Results (Standalone & Consolidated) for fourth quarter and year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of Titan Biotech Limited Held Today I.E. 30Th May 2026",
      "datetime": "30-May-2026",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors at its meeting held today i.e. Saturday 30th May 2026 Approval of Audited Financial Results For The Fourth Quarter And Year Ended 31st March 2026 Recommendation of Dividend re appointment of Cost Auditor and Appointment of Scrutinizer",
      "source": "BSE"
    },
    {
      "caption": "Re-Appointment Of Cost Auditor For Financial Year 2026-2027",
      "datetime": "30-May-2026",
      "details": "Intimation for re-appointment of Cost Auditor of the Company",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Titan Biotech Ltd has declared <strong>20%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Titan Biotech Ltd has announced <strong>2:10</strong> stock split, ex-date: 20 Feb 26",
          "dt": "2026-02-20",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News